NCT01225887 · Interventional trial
Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer
Overall registry status Completed
Phase 2
Conditions Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mucinous Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Squamous Cell Carcinoma, Endometrial Transitional Cell Carcinoma, Endometrial Undifferentiated Carcinoma, Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm, Recurrent Uterine Corpus Carcinoma
Delaware Valley sites
- Abington Memorial Hospital · Abington, PA · Montgomery County
- Lankenau Medical Center · Wynnewood, PA · Montgomery County
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory